• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-甲氧基、1-脱氧-11-羟基和11-羟基-1-甲氧基-Δ(8)-四氢大麻酚:CB2受体的新型选择性配体。

1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptor.

作者信息

Huffman John W, Bushell Simon M, Miller John R A, Wiley Jenny L, Martin Billy R

机构信息

Howard L. Hunter Laboratory, Clemson University, Clemson, SC 29634-1905, USA.

出版信息

Bioorg Med Chem. 2002 Dec;10(12):4119-29. doi: 10.1016/s0968-0896(02)00331-0.

DOI:10.1016/s0968-0896(02)00331-0
PMID:12413866
Abstract

Three series of new cannabinoids were prepared and their affinities for the CB(1) and CB(2) cannabinoid recptors were determined. These are the 1-methoxy-3-(1',1'-dimethylalkyl)-, 1-deoxy-11-hydroxy-3-(1',1'-dimethylalkyl)- and 11-hydroxy-1-methoxy-3-(1',1'-dimethylalkyl)-Delta(8)-tetrahydrocannabinols, which contain alkyl chains from dimethylethyl to dimethylheptyl appended to C-3 of the cannabinoid. All of these compounds have greater affinity for the CB(2) receptor than for the CB(1) receptor, however only 1-methoxy-3-(1',1'-dimethylhexyl)-Delta(8)-THC (JWH-229, 6e) has effectively no affinity for the CB(1) receptor (K(i)=3134+/-110nM) and high affinity for CB(2) (K(i)=18+/-2nM).

摘要

制备了三类新型大麻素,并测定了它们对CB(1)和CB(2)大麻素受体的亲和力。这些是1-甲氧基-3-(1',1'-二甲基烷基)-、1-脱氧-11-羟基-3-(1',1'-二甲基烷基)-和11-羟基-1-甲氧基-3-(1',1'-二甲基烷基)-Δ(8)-四氢大麻酚,它们在大麻素的C-3位连接有从二甲基乙基到二甲基庚基的烷基链。所有这些化合物对CB(2)受体的亲和力都高于对CB(1)受体的亲和力,然而只有1-甲氧基-3-(1',1'-二甲基己基)-Δ(8)-THC (JWH-229, 6e)对CB(1)受体实际上没有亲和力(K(i)=3134±110 nM),而对CB(2)受体具有高亲和力(K(i)=18±2 nM)。

相似文献

1
1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptor.1-甲氧基、1-脱氧-11-羟基和11-羟基-1-甲氧基-Δ(8)-四氢大麻酚:CB2受体的新型选择性配体。
Bioorg Med Chem. 2002 Dec;10(12):4119-29. doi: 10.1016/s0968-0896(02)00331-0.
2
1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.1-溴-3-(1',1'-二甲基烷基)-1-去氧-Δ(8)-四氢大麻醇:大麻素 CB(2)受体的新型选择性配体。
Bioorg Med Chem. 2010 Nov 15;18(22):7809-15. doi: 10.1016/j.bmc.2010.09.061. Epub 2010 Sep 29.
3
3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.3-(1',1'-二甲基丁基)-1-脱氧-δ8-四氢大麻酚及相关化合物:CB2受体选择性配体的合成
Bioorg Med Chem. 1999 Dec;7(12):2905-14. doi: 10.1016/s0968-0896(99)00219-9.
4
Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols.1',1'-二甲基烷基-Δ8-四氢大麻酚的构效关系
Bioorg Med Chem. 2003 Apr 3;11(7):1397-410. doi: 10.1016/s0968-0896(02)00649-1.
5
Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor.1-甲氧基-和1-脱氧-2'-甲基-δ8-四氢大麻酚的对映选择性合成:CB2受体的新型选择性配体
Bioorg Med Chem. 2006 Jan 1;14(1):247-62. doi: 10.1016/j.bmc.2005.08.013. Epub 2005 Sep 13.
6
CB2 receptor ligands.CB2受体配体
Mini Rev Med Chem. 2005 Jul;5(7):641-9. doi: 10.2174/1389557054368844.
7
Synthesis and pharmacology of 11-nor-1-methoxy-9-hydroxyhexahydrocannabinols and 11-nor-1-deoxy-9-hydroxyhexahydrocannabinols: new selective ligands for the cannabinoid CB2 receptor.11-去甲-1-甲氧基-9-羟基六氢大麻酚和11-去甲-1-脱氧-9-羟基六氢大麻酚的合成与药理学:新型大麻素CB2受体选择性配体
Bioorg Med Chem. 2006 Apr 1;14(7):2386-97. doi: 10.1016/j.bmc.2005.11.023.
8
Novel cannabinol probes for CB1 and CB2 cannabinoid receptors.用于CB1和CB2大麻素受体的新型大麻酚探针。
J Med Chem. 2000 Oct 5;43(20):3778-85. doi: 10.1021/jm0001572.
9
Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor.大麻素CB(2)受体选择性配体开发的最新进展。
Curr Top Med Chem. 2008;8(3):187-204. doi: 10.2174/156802608783498014.
10
Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands.冰片基和异冰片基-Δ⁸-四氢大麻酚:一类新型大麻素能配体。
J Med Chem. 2008 Oct 23;51(20):6393-9. doi: 10.1021/jm8005299. Epub 2008 Oct 1.

引用本文的文献

1
Rational drug design of CB2 receptor ligands: from 2012 to 2021.CB2受体配体的合理药物设计:2012年至2021年
RSC Adv. 2022 Dec 8;12(54):35242-35259. doi: 10.1039/d2ra05661e. eCollection 2022 Dec 6.
2
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.靶向内源性大麻素系统:一种针对脑部疾病管理的预测性、预防性和个性化医学指导方法。
EPMA J. 2020 Apr 15;11(2):217-250. doi: 10.1007/s13167-020-00203-4. eCollection 2020 Jun.
3
Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective.
合成与非合成大麻素类药物及其不良反应——基于公共卫生视角的综述
Front Public Health. 2018 Jun 7;6:162. doi: 10.3389/fpubh.2018.00162. eCollection 2018.
4
The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review.大麻素对执行功能的影响:来自大麻和合成大麻素的证据——一项系统综述。
Brain Sci. 2018 Feb 27;8(3):40. doi: 10.3390/brainsci8030040.
5
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.色烯并吡唑,一种在多发性硬化症模型中具有体内活性的多功能大麻素骨架。
J Med Chem. 2016 Jul 28;59(14):6753-6771. doi: 10.1021/acs.jmedchem.6b00397. Epub 2016 Jul 6.
6
Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivatives.氟化大麻素 CB2 受体配体:2-氧代喹啉衍生物的合成及体外结合特性。
Bioorg Med Chem. 2011 Sep 15;19(18):5698-707. doi: 10.1016/j.bmc.2011.07.062. Epub 2011 Aug 5.
7
1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.1-溴-3-(1',1'-二甲基烷基)-1-去氧-Δ(8)-四氢大麻醇:大麻素 CB(2)受体的新型选择性配体。
Bioorg Med Chem. 2010 Nov 15;18(22):7809-15. doi: 10.1016/j.bmc.2010.09.061. Epub 2010 Sep 29.
8
Synthesis and pharmacology of 1-methoxy analogs of CP-47,497.1-甲氧基 CP-47,497 类似物的合成与药理学研究
Bioorg Med Chem. 2010 Aug 1;18(15):5475-82. doi: 10.1016/j.bmc.2010.06.054. Epub 2010 Jun 22.
9
Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.大麻素受体与内源性大麻素的结合:已知和未知。
Curr Med Chem. 2010;17(14):1468-86. doi: 10.2174/092986710790980005.
10
Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands.靶向大麻素CB2受体:CB2选择性配体的建模与结构决定因素
Br J Pharmacol. 2008 Jan;153(2):335-46. doi: 10.1038/sj.bjp.0707567. Epub 2007 Nov 5.